| Members |
targetComponentId |
| Gland symptom NOS |
Finding of thyroid gland |
| Glandelsymptom, ikke nærmere specificeret |
Lacrimal gland finding (finding) |
| Glandelsymptom, ikke nærmere specificeret |
Finding of thyroid gland |
| Gland symptom NOS |
Salivary gland finding |
| Glandelsymptom, ikke nærmere specificeret |
Finding of lymph node |
| Glandulær cyste |
Glandular odontogenic cyst |
| glandulær cyste |
Glandular odontogenic cyst |
| Glandular endometrial hyperplasia |
Endometrial hyperplasia |
| Glandular endometrial hyperplasia |
Complex endometrial hyperplasia |
| Glasgow coma scale finding |
Glasgow coma scale finding (finding) |
| Glasgow coma scale observations |
Glasgow coma scale finding (finding) |
| glasskår i svælget |
Glass in anterior region of neck (disorder) |
| glasskår i svælget |
Glass in pharynx (disorder) |
| Glasser's disease |
Haemophilus infection |
| glatirameracetat 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 1 ml |
Product containing precisely glatiramer acetate 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| glaukom associeret med iridokorneal endotelsyndrom |
Secondary angle-closure glaucoma due to iridocorneal endothelial syndrome |
| Glaucoma associated with pupillary block |
Secondary angle-closure glaucoma with pupil block (disorder) |
| Glaucoma due to eye contusion |
Angle recession glaucoma (disorder) |
| Glaucoma due to eye contusion |
Glaucoma due to and following traumatic injury of globe of eye (disorder) |
| Glaukom forårsaget af okulær tumor eller cyste |
Glaucoma due to ocular cyst |
| Glaukom forårsaget af okulær tumor eller cyste |
Glaucoma due to intraocular neoplasm |
| Glaucoma due to ocular tumour &/or cyst |
Glaucoma due to intraocular neoplasm |
| Glaucoma due to ocular tumour &/or cyst |
Glaucoma due to ocular cyst |
| Glaucoma micro-stent |
Scleral sinus stent |
| Glaucoma of bilateral eyes caused by drug |
Drug-induced angle closure glaucoma of bilateral eyes |
| Glaucoma of bilateral eyes caused by drug |
Drug-induced open angle glaucoma of bilateral eyes |
| Glaucoma of left eye caused by drug |
Open angle glaucoma of left eye caused by drug (disorder) |
| Glaucoma of left eye caused by drug |
Angle closure glaucoma of left eye caused by drug (disorder) |
| Glaucoma of right eye caused by drug |
Drug-induced angle closure glaucoma of right eye |
| Glaucoma of right eye caused by drug |
Open angle glaucoma of right eye caused by drug (disorder) |
| Glaucoma: [primary angle-closure] or [closed angle] |
Angle-closure glaucoma (disorder) |
| Glaucoma: [primary angle-closure] or [closed angle] |
Primary angle-closure glaucoma (disorder) |
| Glauline eye drops 5mL |
Product containing metipranolol (medicinal product) |
| Glenoid augmentation method |
Augmentation of glenoid |
| gliclazid 30 mg tablet med modificeret udløsning |
Product containing precisely gliclazide 30 milligram/1 each prolonged-release oral tablet (clinical drug) |
| Gliomastix-art |
Gliomastix |
| bulbær ftise |
Atrophy of globe of eye |
| bulbær ftise |
Phthisis bulbi |
| Globe of eye shrunken |
Atrophy of globe of eye |
| Globe of eye shrunken |
Phthisis bulbi |
| Globe of eye vestigial |
Cryptophthalmos (disorder) |
| Globe of eye vestigial |
Microphthalmos |
| Globe of eye vestigial |
Anophthalmos |
| Globicatella-art |
Globicatella |
| Globoid cell leukodystrophy, early onset |
Galactosylceramide beta-galactosidase deficiency |
| Globoid cell leukodystrophy, early onset |
Galactosylceramide lipidosis |
| Globoid cell leukodystrophy, early onset |
Galactocerebroside beta-galactosidase deficiency - early onset |
| Glomerulære forstyrrelser ved neoplastiske sygdomme |
Glomerular disease due to neoplastic disease |
| Glossectomy: [NOS] or [NEC] |
Glossectomy |
| Glossodynia |
Burning mouth syndrome (disorder) |
| Glossodynia |
Glossopyrosis (disorder) |
| Glossopharyngeal nerve and its branches |
Entire glossopharyngeal nerve |
| Glossopharyngeal nerve and its branches |
Glossopharyngeal nerve structure |
| Glossopyrosis |
Glossopyrosis (disorder) |
| Glossopyrosis |
Burning mouth syndrome (disorder) |
| Glottis or larynx paralysis (& unspecified) |
Vocal cord paralysis |
| glucagon 1 mg (1 IE) pulver og solvent til injektionsvæske, opløsning |
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Glucagon 1mg(1iu) powder and solvent for injection solution vial |
Product containing precisely glucagon hydrochloride 1 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| glucagontest |
Glucagon measurement |
| glucoaminophosphaturi-syndrom |
Congenital Fanconi syndrome |
| Glucoaminophosphaturi-syndrom med rakit |
Congenital Fanconi syndrome |
| Glucocorticoid derivative |
Glucocorticoid (substance) |
| glucocorticoidhormon |
Glucocorticoid (substance) |
| glucocorticoidhormon |
Adrenal glucocorticoid hormone (substance) |
| glukokortikoidpræparat til systemisk anvendelse |
Product containing glucocorticoid (product) |
| måling af glucohæmoglobin |
Hemoglobin A1c measurement |
| Glucose 6-phosphate dehydrogenase (& [red cell level]) |
Glucose-6-phosphate dehydrogenase measurement |
| Glucose measurement by monitoring device |
Glucose monitoring at home |
| Glucose measurement by monitoring device |
Glucose measurement by monitoring device (procedure) |
| Glucose monitoring system |
Blood glucose monitoring equipment |
| Glucose monitoring system |
Glucose monitoring equipment (physical object) |
| Glucose tolerance (& blood (& test) |
Glucose measurement, post glucose dose |
| Glucose tolerance (& blood (& test) |
Measurement of blood glucose in the fasting state and at specific intervals before and after oral or intravenous glucose load to determine the ability to maintain homeostasis of glucose. |
| Glucose tolerance (& blood (& test) |
Measurement of blood glucose in the fasting state and at specific intervals before and after oral or intravenous glucose load to determine the ability to maintain homeostasis of glucose. |
| Glucose tolerance (& blood (& test) |
Glucose measurement, post glucose dose |
| glucose-6-fosfat-dehydrogenasetest |
Glucose-6-phosphate dehydrogenase measurement |
| Glucose: [intolerance] or [malabsorption] |
Malabsorption of glucose |
| Gluteal muscle (& short hip rotator) |
Muscle of buttock |
| Gluteal muscle (& short hip rotator) |
External rotator of hip joint |
| Gluteal muscle (& short hip rotator) |
Internal rotator of hip joint |
| Glutealt syndrom |
Piriformis syndrome (disorder) |
| Glutealt syndrom |
Myofascial pain |
| Gluten free diet |
Wheat-free diet |
| Gluten free diet |
Gluten free diet |
| glutensensitivitet |
Celiac disease (disorder) |
| glutensensitivitet |
Gluten intolerance |
| Gluten-free/wheat-free baguette |
Gluten-free/wheat-free baguette (product) |
| Gluten-free/wheat-free digestive biscuits |
Gluten-free and wheat-free digestive biscuits (product) |
| Glyburide 1.5mg |
Glibenclamide micronised 1.5 mg oral tablet |
| Glycerol - chemical |
Glycerol |
| Glycerol product |
Product containing glycerol (medicinal product) |
| bivirkning af glycerol/glycol/macrogol |
Adverse reaction to macrogol |
| bivirkning af glycerol/glycol/macrogol |
Adverse reaction to glycol (disorder) |
| bivirkning af glycerol/glycol/macrogol |
Glycerol adverse reaction |
| allergi over for glycerol/glycol/macrogol |
Allergy to glycerin |
| glyceryltrinitrat 10 mg/24 timer depotplaster |
Product containing precisely glyceryl trinitrate 416.667 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| glyceryltrinitrat 15 mg/24 timer depotplaster |
Glyceryl trinitrate 625 microgram/hour prolonged-release transdermal patch |
| glyceryltrinitrat 1 mg/ml injektionsvæske, opløsning, 10 ml ampul |
Glyceryl trinitrate 1 mg/mL solution for injection |
| glyceryltrinitrat 1 mg/ml injektionsvæske, opløsning, 50 ml hætteglas |
Glyceryl trinitrate 1 mg/mL solution for injection |
| glyceryltrinitrat 1 mg/ml injektionsvæske, opløsning, 5 ml ampul |
Glyceryl trinitrate 1 mg/mL solution for injection |
| Glyceryl trinitrate 25mg/5mL injection |
Product containing precisely glyceryl trinitrate 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
FHIR